Thrombospondin-2 (THBS2/TSP2): A Comprehensive Functional Annotation

1. Introduction and Overview

Thrombospondin-2 (TSP2, also known as THBS2; UniProt: P35442) is a secreted, trimeric glycoprotein belonging to the thrombospondin family of matricellular proteins. Unlike structural matrix proteins that provide mechanical support to tissues, TSP2 functions primarily by modulating cell-matrix interactions and influencing the bioavailability of proteases and growth factors in the pericellular environment [bornstein-2000-tsp2-matricellular-abstract]. The protein is synthesized as a precursor of approximately 1172 amino acids in humans and is processed to its mature form upon secretion into the extracellular space.

TSP2 is closely related to thrombospondin-1 (TSP1) and shares substantial structural homology with it, forming the "subgroup A" of the thrombospondin family [calabro-2014-tsp2-ecm-assembly-abstract]. However, TSP2 differs from TSP1 in its temporal and spatial expression patterns and in certain critical functional properties, most notably its inability to activate latent TGF-β [simantov-2005-cd36-antiangiogenic-abstract]. The primary functions of TSP2 include: (1) regulation of extracellular matrix (ECM) assembly and collagen fibrillogenesis; (2) inhibition of angiogenesis through interactions with endothelial cell receptors; (3) modulation of matrix metalloproteinase-2 (MMP2) levels and activity; and (4) regulation of cell-matrix adhesion. These functions make TSP2 a critical regulator of wound healing, tissue repair, bone remodeling, and cardiovascular homeostasis [lawler-2012-angiogenesis-regulation-abstract].

2. Protein Structure and Domain Architecture

TSP2 is a homotrimeric protein, with each monomer of approximately 130-150 kDa connected by disulfide bonds. The modular architecture of TSP2, shared with TSP1, consists of distinct functional domains arranged from the N-terminus to C-terminus [kvansakul-2004-tsp1-structure-abstract]:

N-terminal domain (NTD): This globular domain at the amino terminus contains heparin-binding sites and is involved in interactions with cell surface proteoglycans. The N-terminal region is essential for multimerization into the characteristic trimeric structure.

Procollagen/von Willebrand factor type C (vWC) domain: This domain is thought to participate in protein-protein interactions during ECM assembly.

Three thrombospondin type 1 repeats (TSRs): Also known as properdin-like repeats, these domains are critical for several TSP2 functions including anti-angiogenic activity and interaction with MMP2 [bein-2000-tsp-mmp2-interaction-abstract]. The TSRs contain the CSVTCG (or similar) sequences that are recognized by the scavenger receptor CD36. Importantly, TSP2 contains three TSRs that mediate its antiangiogenic properties through CD36, but unlike TSP1, TSP2 lacks the KRFK sequence required for activation of latent TGF-β [simantov-2005-cd36-antiangiogenic-abstract].

Three EGF-like repeats: These calcium-binding domains (IPR001881, IPR000742, IPR024731) participate in protein-protein interactions and contribute to the structural organization of the signature domain.

Calcium-binding type 3 repeats (T3 repeats): TSP2 contains 13 calcium-binding type 3 repeats (IPR003367), which form a "wire" structure that is critically dependent on calcium ions for proper folding. Crystal structure analysis has revealed that two DxDxDGxxDxxD motifs per repeat each encapsulate two calcium ions in a novel arrangement [kvansakul-2004-tsp1-structure-abstract]. The availability of RGD motifs for cell attachment is modulated by calcium loading, providing a mechanism for conformational regulation of TSP2 function.

C-terminal lectin-like domain (CTD): This globular domain contains a ConA-like lectin fold (IPR013320) and participates in cell-matrix interactions. The CTD forms a β-sandwich structure and contains four strictly conserved calcium-binding sites.

The trimeric assembly of the C-terminal region is necessary for cell spreading and fascin spike organization, indicating that proper oligomerization is essential for biological activity [kvansakul-2004-tsp1-structure-abstract].

3. Molecular Functions and Receptor Interactions

3.1 Regulation of Matrix Metalloproteinase-2 (MMP2)

One of the most well-characterized molecular functions of TSP2 is its regulation of MMP2 levels in the extracellular environment. TSP2 physically interacts with MMP2 through its type 1 repeats (TSRs), which bind to the gelatin-binding domain of MMP2 [bein-2000-tsp-mmp2-interaction-abstract]. This interaction does not directly inhibit MMP2 enzymatic activity; rather, TSP2 facilitates the clearance of MMP2 from the extracellular space through receptor-mediated endocytosis.

The mechanism of MMP2 clearance involves the low-density lipoprotein receptor-related protein (LRP), a scavenger receptor that mediates the internalization of TSP2 [yang-2001-lrp-mmp2-clearance-abstract]. TSP2 forms a complex with MMP2, and this complex is internalized via LRP, effectively reducing extracellular MMP2 levels. In TSP2-null mice, this clearance mechanism is disrupted, leading to a two-fold increase in extracellular MMP2 levels. The elevated MMP2 contributes to several phenotypes observed in TSP2-null mice, including abnormal collagen fibrillogenesis, altered cell adhesion, and increased angiogenesis [yang-2000-mmp2-adhesion-abstract].

3.2 CD36-Mediated Antiangiogenic Activity

TSP2 is a potent endogenous inhibitor of angiogenesis, exerting its effects primarily through the scavenger receptor CD36 [simantov-2005-cd36-antiangiogenic-abstract]. Using the corneal pocket assay, researchers demonstrated that TSP-2 did not inhibit bFGF-induced angiogenesis in CD36-null mice, confirming the essential role of CD36 in mediating TSP2's antiangiogenic activity. TSP2 binds to CD36 through the amino acid region 93-120, the same region that mediates TSP1 binding.

The TSP2-CD36 interaction triggers intracellular signaling cascades that result in inhibition of endothelial cell migration, proliferation, and survival, while promoting apoptosis [lawler-2012-angiogenesis-regulation-abstract]. CD36 and β1 integrins collaborate to transmit these signals, and these receptors appear to associate with VEGFR2 to form a platform for integration of positive and negative signals for angiogenesis. Histidine-rich glycoprotein (HRGP) can act as a "decoy" receptor that binds TSP2 with high affinity and blocks its antiangiogenic activity, suggesting a physiological mechanism for modulating TSP2 function [simantov-2005-cd36-antiangiogenic-abstract].

3.3 FGF2 Binding and Sequestration

Recent studies have identified fibroblast growth factor 2 (FGF2) as an important binding partner for TSP2 [rusnati-2018-fgf2-binding-abstract]. TSP2 binds FGF2 with high affinity (Kd = 1.3 nM) through its calcium-binding type III repeats domain. The minimal FGF2-binding sequence was identified as the GVTDEKD peptide in repeat 3C. This interaction is inhibited by calcium and heparin.

The functional consequence of TSP2-FGF2 binding is impairment of FGF2's ability to interact with its cellular receptors, including heparan sulfate proteoglycans and FGFR-1. By sequestering FGF2, TSP2 reduces the bioavailability of this proangiogenic growth factor, contributing to TSP2's antiangiogenic properties. This mechanism is shared with TSP1, indicating conservation of this growth factor regulatory function within the subgroup A thrombospondins [rusnati-2018-fgf2-binding-abstract].

3.4 CD47 and Integrin Interactions

In addition to CD36, TSP2 interacts with CD47 (also known as integrin-associated protein) and various integrins [lawler-2012-angiogenesis-regulation-abstract]. CD47 is involved in the suppression of nitric oxide (NO) signaling, which contributes to the antiangiogenic and anti-inflammatory effects of TSP2. Both CD36 and CD47 are implicated in the suppression of NO, providing multiple mechanisms for TSP2 to modulate vascular function.

Integrins, particularly αvβ3 and β1 integrins, also serve as receptors for TSP2 effects on cell adhesion and migration [lawler-2012-angiogenesis-regulation-abstract]. Studies in pancreatic cancer have shown that THBS2 binds to integrin αvβ3/CD36 and activates the MAPK pathway in cancer cells [nan-2022-pdac-abstract from the search results].

4. Cellular Localization and Expression

4.1 Subcellular Localization

TSP2 is synthesized in the endoplasmic reticulum and secreted into the extracellular space. The protein contains a signal peptide at its N-terminus that directs it to the secretory pathway. Upon secretion, TSP2 is deposited in the extracellular matrix, where it exerts its matricellular functions. TSP2 does not become an integral structural component of the ECM but rather modulates cell-matrix interactions from its position in the pericellular environment [bornstein-2000-tsp2-matricellular-abstract].

4.2 Tissue Distribution

In normal adult tissues, TSP2 expression is relatively low but can be detected in various connective tissues. The synthesis of TSP2 occurs primarily in connective tissues during development and growth. In the adult, TSP2 expression is markedly induced in response to tissue injury, during wound healing, and in association with tumor growth [bornstein-2000-tsp2-matricellular-abstract].

Key sites of TSP2 expression include:

• Skin and dermis: Fibroblasts are the major cellular source of TSP2 in skin, and expression is upregulated during wound healing [kunkemoeller-2019-diabetic-wound-abstract]
• Bone: TSP2 is expressed by osteoblasts and their progenitors, with particularly high expression during skeletal development and fracture repair [delany-2009-bone-remodeling-abstract]
• Cardiovascular system: TSP2 is expressed in the myocardium and blood vessels, where it plays essential roles in maintaining matrix integrity [schroen-2004-cardiac-tsp2-abstract]
• Eye: TSP2 is expressed in various ocular tissues including the trabecular meshwork, where it may influence intraocular pressure regulation

The temporal expression pattern of TSP2 differs from that of TSP1. While TSP1 is often expressed early in response to injury and is present in platelets (providing an immediate source upon vascular damage), TSP2 expression typically peaks later during the repair process, coinciding with the remodeling phase of wound healing [bornstein-2000-tsp2-matricellular-abstract].

5. Biological Processes and Signaling Pathways

5.1 Extracellular Matrix Assembly and Collagen Fibrillogenesis

TSP2 plays a critical role in regulating ECM assembly and collagen fibrillogenesis without being an integral component of collagen fibrils [calabro-2014-tsp2-ecm-assembly-abstract]. TSP2-null mice display striking abnormalities in connective tissue architecture, including fragile skin, abnormally large collagen fibrils with irregular contours in skin and tendon, and laxity of ligaments [bornstein-2000-tsp2-matricellular-abstract].

Recent mechanistic studies have revealed that TSP2 influences collagen fibrillogenesis through regulation of lysyl oxidase (LOX), an enzyme essential for collagen cross-linking [calabro-2019-mir29-lox-abstract]. TSP2 knockout mice show decreased LOX levels in skin, which manifests as increased fibrillar collagen solubility and decreased levels of LOX-mediated cross-linking. These changes are mediated indirectly through miR-29, a major regulator of ECM proteins and LOX, as miR-29 expression is increased in TSP2-null tissues. Thus, TSP2 contributes to ECM production and assembly by suppressing miR-29 and maintaining adequate LOX levels.

In bone, TSP2 deficiency leads to a brittle bone phenotype characterized by altered collagen fibril morphology and increased detergent-extractable type I collagen [manley-2015-bone-collagen-abstract]. Transmission electron microscopy revealed less intensely stained collagen fibrils with altered morphology in TSP2-null bone, indicating that TSP2 is required for optimal collagen fibrillogenesis in skeletal tissue.

5.2 Wound Healing and Tissue Repair

TSP2 is a critical regulator of the wound healing response. Paradoxically, TSP2-null mice exhibit accelerated wound healing with minimal scarring, suggesting that under normal conditions TSP2 functions to modulate and potentially restrain the healing process [kyriakides-2001-sponge-granuloma-abstract]. TSP2-null wounds show increased angiogenesis, enhanced granulation tissue formation, and altered extracellular matrix remodeling.

The accelerated healing in TSP2-null mice is associated with elevated levels of MMP-2, MMP-9, and soluble VEGF in wounds [maclauchlan-2009-wound-healing-abstract]. However, TSP2-null wound fibroblasts show reduced ability to contract collagen gels, indicating complex effects on wound contracture. The phenotype of TSP2-null mice in wound healing contrasts with that of TSP1-null mice, which show delayed healing with prolonged inflammation [agah-2002-double-null-abstract from search results].

In pathological conditions such as diabetes, elevated TSP2 expression contributes to impaired wound healing. Hyperglycemia increases TSP2 expression in fibroblasts through activation of the hexosamine pathway and NF-κB signaling [kunkemoeller-2019-diabetic-wound-abstract]. Diabetic TSP2-deficient mice exhibit improved healing compared to diabetic control mice, characterized by accelerated re-epithelialization and increased blood vessel maturation, suggesting that targeting TSP2 may be a therapeutic strategy for diabetic wound management.

5.3 Angiogenesis Regulation

TSP2 is one of the most potent endogenous inhibitors of angiogenesis identified to date. The antiangiogenic activity of TSP2 involves multiple mechanisms [lawler-2012-angiogenesis-regulation-abstract]:

1. Direct effects on endothelial cells: TSP2 inhibits endothelial cell migration, proliferation, and survival while promoting apoptosis through CD36 and CD47 signaling
2. VEGF antagonism: TSP2 antagonizes VEGF activity, in part through receptor cross-talk at the plasma membrane
3. FGF2 sequestration: TSP2 binds and sequesters FGF2, reducing its bioavailability for proangiogenic signaling
4. MMP regulation: By facilitating MMP2 clearance, TSP2 limits matrix degradation necessary for endothelial cell migration and vessel sprouting

These antiangiogenic properties have been exploited in tumor models, where TSP2 overexpression suppresses tumor growth through inhibition of tumor angiogenesis [de-fraipont-2001-tsp-angiogenesis from search results].

5.4 Bone Formation and Remodeling

TSP2 plays important roles in skeletal development and bone remodeling. TSP2-null mice have higher cortical bone volume and increased endosteal bone growth, attributed to expansion of the osteoblast progenitor cell pool [delany-2009-bone-remodeling-abstract]. However, these progenitors display deficits in osteoblastic differentiation potential, with delayed formation of mineralized matrix in vitro.

TSP2 influences the proportion of cartilage and bone during fracture healing [taylor-2009-fracture-healing-abstract]. TSP2-null mice show 30% more bone and 40% less cartilage by 10 days post-fracture compared to wild-type controls. This phenotype is attributed to increased vascularization in TSP2-null fracture calluses, which increases tissue oxygenation and shifts mesenchymal cell fate toward osteoblastic rather than chondrocytic differentiation. TSP2-null mice are also resistant to bone loss associated with ovariectomy, suggesting a role in estrogen-dependent bone regulation [hankenson-2010-bone-regulation-abstract].

5.5 Cardiovascular Function

TSP2 is essential for maintaining the structural integrity of the cardiac matrix [schroen-2004-cardiac-tsp2-abstract]. In a seminal study, researchers found that TSP2 expression was selectively elevated in hypertrophied hearts that were prone to progress to heart failure. Angiotensin II treatment induced fatal cardiac rupture in 70% of TSP2-null mice, while surviving animals developed heart failure—phenotypes not observed in wild-type mice. This dramatic finding demonstrates that TSP2 is necessary for the myocardium to cope with increased mechanical loading.

The protective function of TSP2 in the heart is attributed to its regulation of MMP activity. TSP2-null hearts showed markedly elevated MMP-2 and MMP-9 activity following angiotensin II treatment, leading to excessive matrix degradation and loss of structural integrity. Thus, TSP2 serves as a crucial regulator of the balance between matrix synthesis and degradation in the stressed myocardium [schroen-2004-cardiac-tsp2-abstract].

6. Role in Disease

6.1 Cancer

TSP2 has been implicated in various cancers with context-dependent effects. In many solid tumors, TSP2 expression correlates with reduced angiogenesis and improved prognosis due to its antiangiogenic properties. However, in some cancer types, elevated TSP2 expression is associated with poor outcomes.

In gastric cancer, THBS2 is overexpressed in cancer-associated fibroblasts (CAFs) and contributes to immune checkpoint blockade resistance through promotion of immunosuppressive tumor microenvironment features [li-2024-gastric-cancer-abstract from search results]. THBS2+ matrix CAFs facilitate recruitment of tissue-resident macrophages and their transformation into SPP1+ tumor-associated macrophages via the complement C3-C3AR1 axis.

In colorectal cancer, the lncRNA RP11-417E7.1 promotes metastasis by activating THBS2 transcription, which then activates the Wnt/β-catenin pathway and facilitates M2 macrophage polarization [liu-2024-crc-abstract from search results].

TSP2 has shown potential as a diagnostic biomarker, particularly in pancreatic ductal adenocarcinoma (PDAC) where elevated serum TSP2 levels correlate with tumor progression [nan-2022-pdac-abstract from search results].

6.2 Diabetic Complications

As discussed above, elevated TSP2 expression in diabetes contributes to impaired wound healing. TSP2 expression is increased in diabetic mice and in skin from patients with diabetes [kunkemoeller-2019-diabetic-wound-abstract]. Therapeutic strategies aimed at reducing TSP2 levels may improve wound healing outcomes in diabetic patients.

6.3 Cardiovascular Disease

TSP2 has been identified as a potential biomarker for heart failure risk. Elevated plasma TSP2 levels predict incident heart failure and are associated with echocardiographic traits indicative of cardiac remodeling [nayor-2020-biomarkers-abstract from search results]. The essential role of TSP2 in maintaining cardiac matrix integrity makes it a potential therapeutic target for preventing adverse cardiac remodeling.

7. Open Questions

Despite significant progress in understanding TSP2 function, several important questions remain:

1. Tissue-specific regulation of TSP2 expression: While TSP2 is induced in response to injury, the specific transcription factors and signaling pathways that control TSP2 expression in different tissues remain incompletely characterized. The regulation of TSP2 expression differs substantially from TSP1, reflecting distinct promoter sequences, but the functional significance of these differences requires further investigation.

2. Relative contributions of different TSP2 domains: TSP2 contains multiple functional domains that interact with different binding partners. The relative importance of each domain for specific biological functions, and whether there is crosstalk between domains, is not fully understood.

3. TSP2 and TGF-β: Unlike TSP1, TSP2 lacks the ability to activate latent TGF-β and may even competitively inhibit TSP1-mediated TGF-β activation. The consequences of this differential activity for tissue homeostasis and disease remain to be fully elucidated.

4. Cell type-specific effects: TSP2 affects multiple cell types including fibroblasts, endothelial cells, and osteoblasts. Understanding how TSP2 exerts different effects on different cell types will be important for developing targeted therapeutic interventions.

5. Therapeutic applications: Given its roles in angiogenesis, wound healing, and matrix remodeling, TSP2 or TSP2-derived peptides have therapeutic potential. However, the dual effects of TSP2 in different contexts (e.g., beneficial antiangiogenic effects in tumors but potentially detrimental effects in diabetic wound healing) present challenges for therapeutic development.

6. Relationship with aging: TSP2 levels increase in aged tissues, but the consequences of this increased expression for age-related tissue dysfunction require further investigation [agah-2004-aging-abstract from search results].

7. Signaling pathway integration: How TSP2-initiated signals integrate with other signaling pathways, particularly those controlling ECM homeostasis and angiogenesis, remains an active area of investigation.

8. References

1. bornstein-2000-tsp2-matricellular: Bornstein P, Armstrong LC, Hankenson KD, Kyriakides TR, Yang Z. Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol. 2000 Dec;19(7):557-68. DOI: https://doi.org/10.1016/s0945-053x(00)00104-9 PMID: 11102746

2. calabro-2014-tsp2-ecm-assembly: Calabro NE, Kristofik NJ, Kyriakides TR. Thrombospondin-2 and extracellular matrix assembly. Biochim Biophys Acta. 2014 Aug;1840(8):2396-402. DOI: https://doi.org/10.1016/j.bbagen.2014.01.013 PMID: 24440155 PMCID: PMC4074560

3. lawler-2012-angiogenesis-regulation: Lawler PR, Lawler J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harb Perspect Med. 2012 May;2(5):a006627. DOI: https://doi.org/10.1101/cshperspect.a006627 PMID: 22553494 PMCID: PMC3331684

4. yang-2000-mmp2-adhesion: Yang Z, Kyriakides TR, Bornstein P. Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol Biol Cell. 2000 Oct;11(10):3353-64. DOI: https://doi.org/10.1091/mbc.11.10.3353 PMID: 11029041 PMCID: PMC14997

5. simantov-2005-cd36-antiangiogenic: Simantov R, Febbraio M, Silverstein RL. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein. Matrix Biol. 2005 Jan;24(1):27-34. DOI: https://doi.org/10.1016/j.matbio.2004.11.005 PMID: 15748999

6. bein-2000-tsp-mmp2-interaction: Bein K, Simons M. Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity. J Biol Chem. 2000 Oct 13;275(41):32167-73. DOI: https://doi.org/10.1074/jbc.M003834200 PMID: 10900205

7. yang-2001-lrp-mmp2-clearance: Yang Z, Strickland DK, Bornstein P. Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. J Biol Chem. 2001 Mar 16;276(11):8403-8. DOI: https://doi.org/10.1074/jbc.M008925200 PMID: 11113133

8. schroen-2004-cardiac-tsp2: Schroen B, Heymans S, Sharma U, et al. Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ Res. 2004 Aug 20;95(5):515-22. DOI: https://doi.org/10.1161/01.RES.0000141019.20332.3e PMID: 15284191

9. rusnati-2018-fgf2-binding: Rusnati M, Borsotti P, Moroni E, et al. The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2). Angiogenesis. 2019 Feb;22(1):133-144. DOI: https://doi.org/10.1007/s10456-018-9644-3 PMID: 30168023

10. calabro-2019-mir29-lox: Calabro NE, Barrett A, Chamorro-Jorganes A, et al. Thrombospondin-2 regulates extracellular matrix production, LOX levels, and cross-linking via downregulation of miR-29. Matrix Biol. 2019 Sep;82:71-85. DOI: https://doi.org/10.1016/j.matbio.2019.03.002 PMID: 30876926 PMCID: PMC6710120

11. kunkemoeller-2019-diabetic-wound: Kunkemoeller B, Bancroft T, Xing H, et al. Elevated Thrombospondin 2 Contributes to Delayed Wound Healing in Diabetes. Diabetes. 2019 Oct;68(10):2016-2023. DOI: https://doi.org/10.2337/db18-1001 PMID: 31391172 PMCID: PMC6754242

12. kvansakul-2004-tsp1-structure: Kvansakul M, Adams JC, Hohenester E. Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats. EMBO J. 2004 Mar 24;23(6):1223-33. DOI: https://doi.org/10.1038/sj.emboj.7600166 PMID: 15014436 PMCID: PMC381422

13. taylor-2009-fracture-healing: Taylor DK, Meganck JA, Terkhorn S, et al. Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing. J Bone Miner Res. 2009 Jun;24(6):1043-54. DOI: https://doi.org/10.1359/jbmr.090101 PMID: 19123916 PMCID: PMC3276350

14. delany-2009-bone-remodeling: Delany AM, Hankenson KD. Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling. J Cell Commun Signal. 2009 Dec;3(3-4):227-38. DOI: https://doi.org/10.1007/s12079-009-0076-0 PMID: 19862642 PMCID: PMC2778593

15. hankenson-2010-bone-regulation: Hankenson KD, Sweetwyne MT, Shitaye H, Posey KL. Thrombospondins and novel TSR-containing proteins, R-spondins, regulate bone formation and remodeling. Curr Osteoporos Rep. 2010 Jun;8(2):68-76. DOI: https://doi.org/10.1007/s11914-010-0017-0 PMID: 20425613

16. kyriakides-2001-sponge-granuloma: Kyriakides TR, Zhu YH, Yang Z, Huynh G, Bornstein P. Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice. Am J Pathol. 2001 Oct;159(4):1255-62. DOI: https://doi.org/10.1016/S0002-9440(10)62512-6 PMID: 11583953 PMCID: PMC1850515

17. maclauchlan-2009-wound-healing: Maclauchlan S, Skokos EA, Agah A, et al. Enhanced angiogenesis and reduced contraction in thrombospondin-2-null wounds is associated with increased levels of matrix metalloproteinases-2 and -9, and soluble VEGF. J Histochem Cytochem. 2009 Apr;57(4):301-13. DOI: https://doi.org/10.1369/jhc.2008.952689 PMID: 19029404 PMCID: PMC2664984

18. manley-2015-bone-collagen: Manley E, Perosky JE, Khoury BM, Reddy AB, Kozloff KM, Alford AI. Thrombospondin-2 deficiency in growing mice alters bone collagen ultrastructure and leads to a brittle bone phenotype. J Appl Physiol. 2015 Oct 15;119(8):872-81. DOI: https://doi.org/10.1152/japplphysiol.00340.2015 PMID: 26272319 PMCID: PMC4610004

19. zhang-2020-cardiovascular: Zhang K, Li M, Yin L, Fu G, Liu Z. Role of thrombospondin-1 and thrombospondin-2 in cardiovascular diseases (Review). Int J Mol Med. 2020 May;45(5):1275-1293. DOI: https://doi.org/10.3892/ijmm.2020.4507 PMID: 32323748 PMCID: PMC7138268

20. bornstein-2004-injury-response: Bornstein P, Agah A, Kyriakides TR. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int J Biochem Cell Biol. 2004 Jun;36(6):1115-25. DOI: https://doi.org/10.1016/j.biocel.2004.01.012 PMID: 15094126

Citations

1. bein-2000-tsp-mmp2-interaction-abstract.md
2. bornstein-2000-tsp2-matricellular-abstract.md
3. calabro-2014-tsp2-ecm-assembly-abstract.md
4. calabro-2019-mir29-lox-abstract.md
5. delany-2009-bone-remodeling-abstract.md
6. hankenson-2010-bone-regulation-abstract.md
7. kunkemoeller-2019-diabetic-wound-abstract.md
8. kvansakul-2004-tsp1-structure-abstract.md
9. kyriakides-2001-sponge-granuloma-abstract.md
10. lawler-2012-angiogenesis-regulation-abstract.md
11. maclauchlan-2009-wound-healing-abstract.md
12. manley-2015-bone-collagen-abstract.md
13. rusnati-2018-fgf2-binding-abstract.md
14. schroen-2004-cardiac-tsp2-abstract.md
15. simantov-2005-cd36-antiangiogenic-abstract.md
16. taylor-2009-fracture-healing-abstract.md
17. yang-2000-mmp2-adhesion-abstract.md
18. yang-2001-lrp-mmp2-clearance-abstract.md

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan and verification
- Identity check: THBS2 (UniProt P35442) encodes human thrombospondin‑2, a secreted matricellular glycoprotein of the thrombospondin family. Recent primary studies explicitly describe THBS2 as an extracellular, disulfide‑linked homotrimeric thrombospondin released by stromal cells, consistent with UniProt and the thrombospondin family/domain architecture; no evidence of symbol ambiguity was found in human literature cited here (Zhang et al., JHEP Reports, 2024; Hadar et al., EJHG, 2024) (zhang2024targetingthrombospondin2retards pages 1-3, hadar2024heterozygousthbs2pathogenic pages 1-2).

1) Key concepts and definitions
- Protein class and structure: THBS2 is a secreted matricellular thrombospondin that assembles into disulfide‑linked homotrimers and resides in the extracellular matrix (ECM), modulating cell–matrix signaling rather than serving as a structural fibril itself (JHEP Reports, 2024; EJHG, 2024) (zhang2024targetingthrombospondin2retards pages 1-3, hadar2024heterozygousthbs2pathogenic pages 1-2). THBS2’s modular architecture (N‑terminal coiled-coil/oligomerization, von Willebrand factor C-like and EGF-like modules, and multiple thrombospondin type 1 repeats) underlies interactions with ECM ligands and receptors including integrins, CD36, and proteases; functional engagement of integrins and CD36 is noted in recent cancer work (IJMS, 2024) (corbella2024thbs1andthbs2 pages 7-8). Subcellular localization: secreted to the extracellular space and deposited in the ECM (JHEP Reports, 2024; Scientific Reports, 2024) (zhang2024targetingthrombospondin2retards pages 1-3, jerala2024thrombospondin2matrix pages 1-2).
- Core molecular functions: (i) regulation of collagen fibrillogenesis/ECM assembly; (ii) modulation of protease activity and clearance (notably MMP2); (iii) receptor-mediated signaling affecting angiogenesis, fibrogenesis, and inflammation through pathways including TLR4→FAK/TGF‑β/SMAD, and, in cancer contexts, Notch and EGFR/PI3K–Akt–mTOR axes (EJHG, 2024; JHEP Reports, 2024; AJCR, 2024; IJMS, 2024) (hadar2024heterozygousthbs2pathogenic pages 1-2, zhang2024targetingthrombospondin2retards pages 1-3, corbella2024thbs1andthbs2 pages 7-8).

2) Recent developments and latest research (2023–2024 focus)
- Fibrosis—liver: THBS2 produced by activated hepatic stellate cells (HSCs) directly binds TLR4 to drive profibrotic signaling via FAK and TGF‑β/SMAD2/3. AAV6 shRNA targeting Thbs2 in HSCs reduced intrahepatic inflammation and fibrosis in CCl4 and MCD mouse models (Zhang et al., JHEP Reports; online 24 Jan 2024; 6:101014; https://doi.org/10.1016/j.jhepr.2024.101014) (zhang2024targetingthrombospondin2retards pages 1-3, zhang2024targetingthrombospondin2retards pages 10-11). In LX‑2 HSCs, THBS2 peptide (1 μg/mL, 24 h) increased COL1 and p‑SMAD2; TGF‑β inhibitor LY2157299 (1 μM) and FAK inhibitor PF‑562271 (1 μM) attenuated these readouts, supporting a TLR4→FAK/TGF‑β axis (zhang2024targetingthrombospondin2retards pages 10-11).
- Fibrosis—NAFLD: In human datasets and HSC models, THBS2 strongly correlates with collagen genes and is induced by TGF‑β; knockdown reduces COL1A1 and collagen fiber accumulation, while recombinant THBS2 increases COL1A1. Single‑cell and in situ analyses localize THBS2 to HSCs (bioRxiv preprint, Jun 2023; https://doi.org/10.1101/2023.06.01.543250) (kimura2023thrombospondin2is pages 5-10).
- Fibrosis—Crohn’s disease: THBS2 is significantly upregulated in subserosal fibroblasts of fibrostenosing Crohn’s disease, with distinct collagen architecture (thicker, more tortuous fibers) compared to submucosa, indicating layer‑specific fibroblast states; CD36 is referenced as a THBS2 receptor in this context (Scientific Reports, 10 Jun 2024; https://doi.org/10.1038/s41598-024-64672-7) (jerala2024thrombospondin2matrix pages 1-2).
- Cancer—cholangiocarcinoma: Recombinant human THBS2 (≈100 ng/mL) enhances iCCA cell proliferation, adhesion, migration, and invasion, with stronger EMT‑like effects than THBS1; authors discuss integrin engagement and EGFR upregulation leading to PI3K/Akt/mTOR activation (Int J Mol Sci, 8 Feb 2024; https://doi.org/10.3390/ijms25031782) (corbella2024thbs1andthbs2 pages 7-8).
- Cancer—gastric: THBS2 promotes gastric cancer progression and stemness via Notch signaling (regulating Notch3/HES1), and is negatively regulated by miR‑29b‑3p; THBS2 downregulation impairs tumorigenesis and liver metastasis in xenografts (Am J Cancer Res, 2024; https://doi.org/10.62347/uxwk4038) (corbella2024thbs1andthbs2 pages 7-8).
- Human genetics—connective tissue disease: A heterozygous THBS2 missense variant (p.Cys896Arg) causes a dominantly inherited Ehlers–Danlos–like syndrome with vascular features in humans; CRISPR knock‑in mice reproduce key phenotypes. Mechanistically, THBS2 normally binds MMP2 to mediate its clearance; loss‑of‑function reduces MMP2 clearance, increasing proteoglycan cleavage and causing ECM disorganization with vascular consequences (Eur J Hum Genet, 18 Mar 2024; https://doi.org/10.1038/s41431-024-01559-1) (hadar2024heterozygousthbs2pathogenic pages 1-2).

3) Current applications and real‑world implementations
- Therapeutic targeting of fibrogenesis: Preclinical AAV6‑shRNA silencing of Thbs2 in HSCs attenuates liver fibrosis in multiple models, nominating THBS2 as a stromal therapeutic target irrespective of etiology (JHEP Reports, 2024) (zhang2024targetingthrombospondin2retards pages 1-3, zhang2024targetingthrombospondin2retards pages 10-11).
- Diagnostic/biomarker directions: Disease‑tissue studies show layer‑specific THBS2 upregulation in fibrostenosing Crohn’s disease and strong associations with activated fibroblast states; these support histopathologic and digital pathology workflows for stratifying fibrosis and fibroblast populations (Sci Rep, 2024) (jerala2024thrombospondin2matrix pages 1-2). In oncology, THBS2 elevation corresponds to invasive phenotypes in iCCA and supports tumor progression/stemness in gastric cancer, suggesting utility in risk stratification and potentially as a circulating biomarker in selected cancers (IJMS, 2024) (corbella2024thbs1andthbs2 pages 7-8).

4) Expert opinions and authoritative synthesis
- Recent mechanobiology review underscores thrombospondins as mechanosensitive ECM effectors linking matrix stiffening to TGF‑β and NF‑κB signaling; THBS2 participates in fibrosis and tumorigenesis under altered mechanical cues, aligning with its induction in fibrotic tissues and tumor microenvironments (Cell Communication and Signaling, 2025; review cites 2023–2024 primary work including JHEP Reports 2024) (zhao2025themechanobiologyof pages 17-17). Together with primary data above, the consensus places THBS2 as a context‑dependent modulator of ECM‑receptor signaling governing fibroblast activation, collagen deposition, and tumor cell behavior (zhang2024targetingthrombospondin2retards pages 1-3, kimura2023thrombospondin2is pages 5-10, jerala2024thrombospondin2matrix pages 1-2, corbella2024thbs1andthbs2 pages 7-8).

5) Relevant statistics and quantitative data (selected 2023–2024)
- HSCs/liver fibrosis: THBS2 peptide 1 μg/mL for 24 h increased COL1 and p‑SMAD2 in LX‑2; pathway inhibition with LY2157299 (1 μM; TGF‑β) or PF‑562271 (1 μM; FAK) reduced these readouts, supporting a TLR4→FAK/TGF‑β axis (JHEP Reports, 2024; DOI above) (zhang2024targetingthrombospondin2retards pages 10-11). AAV6‑shRNA against Thbs2 reduced fibrosis progression in CCl4 and MCD models (zhang2024targetingthrombospondin2retards pages 1-3).
- NAFLD/HSCs: THBS2 mRNA >160‑fold higher in LX‑2 vs. HepG2; TGF‑β induced THBS2 (P<0.0001); THBS2 peaked ≈10 h before COL1A1; THBS2 siRNA (~50% knockdown) reduced COL1A1 (P=0.0046); recombinant THBS2 increased COL1A1 (P=0.0051) (bioRxiv, 2023) (kimura2023thrombospondin2is pages 5-10).
- Crohn’s fibrostenosis: Significant qPCR upregulation of THBS2 in subserosa vs. submucosa; digital pathology quantified thicker, more tortuous, reticulated collagen fibers in subserosal fibrosis (Sci Rep, 2024) (jerala2024thrombospondin2matrix pages 1-2).
- iCCA: Recombinant THBS2 (100 ng/mL) increased adhesion, migration, invasion; stronger EMT‑like phenotype vs THBS1 in HuCCT‑1; analysis linked THBS2 to a poor‑prognosis proteogenomic subgroup (IJMS, 2024) (corbella2024thbs1andthbs2 pages 7-8).
- Human genetics: THBS2 p.Cys896Arg associated with joint hypermobility, atrophic scarring, prolonged bleeding, and age‑related aortic dilatation/rupture in a pedigree; KI mice recapitulated phenotypes, supporting a pathogenic mechanism via impaired MMP2 clearance and ECM disorganization (EJHG, 2024) (hadar2024heterozygousthbs2pathogenic pages 1-2).

Mechanistic pathway mapping for THBS2
- ECM and collagen regulation: THBS2 modulates collagen fibrillogenesis and ECM organization; genetic disruption leads to disorganized collagen and abnormal ECM ultrastructure in human/mouse (EJHG, 2024) (hadar2024heterozygousthbs2pathogenic pages 1-2). In fibrotic liver and NAFLD, THBS2 upregulation in HSCs precedes COL1A1 induction and increases collagen gene expression and matrix deposition (JHEP Reports, 2024; bioRxiv, 2023) (zhang2024targetingthrombospondin2retards pages 1-3, kimura2023thrombospondin2is pages 5-10).
- Receptor interactions: Direct extracellular binding to TLR4 on HSCs initiates FAK and TGF‑β/SMAD signaling to activate fibrogenesis (JHEP Reports, 2024) (zhang2024targetingthrombospondin2retards pages 1-3, zhang2024targetingthrombospondin2retards pages 10-11). Engagement of integrins and CD36 is supported by iCCA and Crohn’s disease fibrosis contexts (IJMS, 2024; Sci Rep, 2024) (corbella2024thbs1andthbs2 pages 7-8, jerala2024thrombospondin2matrix pages 1-2). Cancer studies indicate coupling to Notch signaling (Notch3/HES1) and potential EGFR upregulation (AJCR, 2024; IJMS, 2024) (corbella2024thbs1andthbs2 pages 7-8).
- Protease regulation: THBS2 binds MMP2 and mediates its clearance; pathogenic variants undermine MMP2 clearance, increasing proteoglycan cleavage and causing ECM defects (EJHG, 2024) (hadar2024heterozygousthbs2pathogenic pages 1-2).
- Angiogenesis and inflammation: As a matricellular cue, THBS2 influences angiogenesis and inflammatory signaling; fibrotic and cancer contexts reveal elevated THBS2 associated with profibrotic cytokine signaling (TGF‑β/SMAD) and invasive/EMT‑like programs (JHEP Reports, 2024; IJMS, 2024) (zhang2024targetingthrombospondin2retards pages 1-3, corbella2024thbs1andthbs2 pages 7-8).

Where THBS2 functions
- THBS2 is secreted and functions in the extracellular milieu/ECM at the interface of stromal cells (e.g., HSCs, fibroblasts), endothelial and immune cells, acting through cell‑surface receptors and ECM ligand binding to control matrix assembly and cell behavior (JHEP Reports, 2024; Sci Rep, 2024) (zhang2024targetingthrombospondin2retards pages 1-3, jerala2024thrombospondin2matrix pages 1-2).

Applications and implementation examples
- Preclinical anti‑fibrotic strategy: Cell‑type–targeted THBS2 silencing (AAV6‑shRNA to HSCs) retards fibrosis progression across etiologies in mouse liver models, demonstrating a feasible in vivo intervention strategy and providing a translational rationale for THBS2‑directed therapeutics (JHEP Reports, 2024) (zhang2024targetingthrombospondin2retards pages 1-3, zhang2024targetingthrombospondin2retards pages 10-11).
- Pathology stratification: THBS2 immunostaining/qPCR coupled with digital collagen analysis separates submucosal vs subserosal fibroblast populations and matrix architectures in fibrostenosing Crohn’s disease, an approach applicable to precision pathology and surgical planning (Sci Rep, 2024) (jerala2024thrombospondin2matrix pages 1-2).
- Oncology: THBS2 promotes invasive phenotypes in iCCA and supports Notch‑dependent stemness and metastasis in gastric cancer; these data support exploration of THBS2 as a tumor microenvironmental target and as a tissue/circulating biomarker in select indications (IJMS, 2024) (corbella2024thbs1andthbs2 pages 7-8).

Embedded summary of recent primary studies
| Study (year) | Context | Models | Mechanism / Pathway | Quantitative / Key Data | Link (DOI, month/year) |
|---|---|---|---|---|---|
| Zhang et al., 2024 (zhang2024targetingthrombospondin2retards pages 1-3) | Liver fibrosis | Mouse models (CCl4, MCD), primary HSCs, LX-2; AAV6-shRNA targeting Thbs2 | Extracellular THBS2 binds TLR4 → activates FAK and TGF-β/Smad2 in HSCs (autocrine) | AAV6-shRNA reduced inflammation & fibrosis; THBS2 peptide (1 µg/mL) altered COL1, p-SMAD2; used LY2157299 (TGF-β inhibitor) and PF-562271 (FAK inhibitor) in assays | https://doi.org/10.1016/j.jhepr.2024.101014 (Jan/Mar 2024) |
| Kimura et al., 2023 (kimura2023thrombospondin2is pages 5-10) | NAFLD / hepatic fibrogenesis | Human HSCs (LX-2), HepG2, scRNA-seq, siRNA knockdown, recombinant TSP2 | THBS2 correlates with collagen genes and is induced by TGF-β; modulates collagen fibrillogenesis and acts upstream of COL1A1 (SMAD-independent signals reported) | THBS2 mRNA >160× in LX-2 vs HepG2; TGF-β induction P<0.0001; siRNA ~50% knockdown reduced COL1A1 (P=0.0046); THBS2 peaks ~10 h before COL1A1 | https://doi.org/10.1101/2023.06.01.543250 (Jun 2023) |
| Jerala et al., 2024 (jerala2024thrombospondin2matrix pages 1-2) | Fibrostenosing Crohn’s disease (fibrosis) | Human tissue IHC, qPCR, digital pathology | THBS2 upregulated in CD subserosa; marks distinct fibroblast populations; implicated receptor: CD36 noted | Significant THBS2 upregulation in subserosa vs submucosa by qPCR; digital pathology shows thicker, more tortuous collagen fibres in subserosal fibrosis | https://doi.org/10.1038/s41598-024-64672-7 (Jun 2024) |
| Corbella et al., 2024 (corbella2024thbs1andthbs2 pages 7-8) | Intrahepatic cholangiocarcinoma (iCCA) | Human iCCA cell lines (HuCCT-1, CCLP1); recombinant human THBS2 | THBS2 promotes proliferation, adhesion, migration, invasion; engages integrins and may upregulate EGFR → PI3K/Akt/mTOR; stronger EMT-like effects than THBS1 | rhTHBS2 (100 ng/mL) increased invasiveness and EMT-like phenotype; associated with poor-prognosis proteogenomic subgroup | https://doi.org/10.3390/ijms25031782 (Feb 2024) |
| Chang et al., 2024 | Gastric cancer | Human GC tissues, cell lines, xenografts; miRNA assays (dual-luciferase) | THBS2 promotes tumor progression and stemness via Notch signaling (Notch3, HES1); regulated by miR-29b-3p | THBS2 downregulation impaired tumorigenesis and liver metastasis in xenograft models; tissue analyses on paired specimens | https://doi.org/10.62347/uxwk4038 (2024) |
| Liu et al., 2023 | Pulmonary fibrosis / IPF (mouse bleomycin model) | Bleomycin mouse model, hESC-derived exosomes in vivo and in vitro, luciferase assays | Exosomal miR-17-5p targets THBS2 (miR-17-5p → THBS2) to reduce inflammation and fibrosis | hESC-exosome administration alleviated bleomycin-induced fibrosis; Thbs2 elevated after BLM induction; luciferase confirmed direct targeting | https://doi.org/10.1186/s13287-023-03449-7 (Sep 2023) |
| Hadar et al., 2024 (hadar2024heterozygousthbs2pathogenic pages 1-2) | Ehlers–Danlos syndrome with vascular features | Human pedigree genetic analysis; CRISPR/Cas9 knock-in mice (THBS2 p.Cys896Arg); histology, TEM, bleeding assays | Heterozygous THBS2 pathogenic variant impairs MMP2 clearance (THBS2–MMP2 interaction), leading to ECM disorganization, proteoglycan cleavage and vascular/connective tissue defects | Phenotype: joint hypermobility, atrophic scarring, prolonged bleeding time, age-related aortic dilatation/rupture; KI mice recapitulate human features | https://doi.org/10.1038/s41431-024-01559-1 (Mar 2024) |

Table: Concise table summarizing primary 2023–2024 studies on human THBS2, listing context, models, key mechanisms/pathways, quantitative highlights, and DOI links for quick reference and citation.

Limitations and open questions
- Some mechanistic threads (e.g., breadth of integrin specificity, direct structural mapping of TSR‑receptor contacts, cell‑type–specific effects on angiogenesis) remain incompletely resolved in 2023–2024 literature and may be context dependent. Preprint data (NAFLD) require peer‑reviewed confirmation (kimura2023thrombospondin2is pages 5-10).

Conclusion
THBS2 (UniProt P35442) is a human secreted thrombospondin that operates in the ECM to regulate collagen fibrillogenesis, protease (MMP2) activity/clearance, and receptor‑mediated signaling. Recent studies position THBS2 as a stromal driver of fibrogenesis via a TLR4→FAK/TGF‑β axis in liver and as a marker/effector of fibroblast states in intestinal fibrosis. In cancer, THBS2 promotes invasion and stemness through integrin/EGFR and Notch signaling. Human genetics show that disrupting THBS2’s ECM‑modulatory role underlies an Ehlers–Danlos–like vascular syndrome via impaired MMP2 clearance. These findings motivate therapeutic targeting of THBS2 in fibrosis and support its evaluation as a biomarker and microenvironmental target in oncology (zhang2024targetingthrombospondin2retards pages 1-3, zhang2024targetingthrombospondin2retards pages 10-11, kimura2023thrombospondin2is pages 5-10, jerala2024thrombospondin2matrix pages 1-2, corbella2024thbs1andthbs2 pages 7-8, hadar2024heterozygousthbs2pathogenic pages 1-2).

References

1. (zhang2024targetingthrombospondin2retards pages 1-3): Ning Zhang, Xiaoning Wu, Wen Zhang, Yameng Sun, Xuzhen Yan, Anjian Xu, Qi Han, Aiting Yang, Hong You, and Wei Chen. Targeting thrombospondin-2 retards liver fibrosis by inhibiting tlr4-fak/tgf-β signaling. JHEP Reports, 6:101014, Mar 2024. URL: https://doi.org/10.1016/j.jhepr.2024.101014, doi:10.1016/j.jhepr.2024.101014. This article has 14 citations and is from a peer-reviewed journal.

2. (hadar2024heterozygousthbs2pathogenic pages 1-2): Noam Hadar, Omri Porgador, Idan Cohen, Hilla Levi, Vadim Dolgin, Yuval Yogev, Sufa Sued-Hendrickson, Ilan Shelef, Elena Didkovsky, Marina Eskin-Schwartz, and Ohad S. Birk. Heterozygous thbs2 pathogenic variant causes ehlers-danlos syndrome with prominent vascular features in humans and mice. European journal of human genetics : EJHG, 32:550-557, Mar 2024. URL: https://doi.org/10.1038/s41431-024-01559-1, doi:10.1038/s41431-024-01559-1. This article has 18 citations.

3. (corbella2024thbs1andthbs2 pages 7-8): Eleonora Corbella, Claudia Fara, Francesca Covarelli, Veronica Porreca, Biagio Palmisano, Giuseppina Mignogna, Alessandro Corsi, Mara Riminucci, Bruno Maras, and Carmine Mancone. Thbs1 and thbs2 enhance the in vitro proliferation, adhesion, migration and invasion of intrahepatic cholangiocarcinoma cells. International Journal of Molecular Sciences, 25:1782, Feb 2024. URL: https://doi.org/10.3390/ijms25031782, doi:10.3390/ijms25031782. This article has 14 citations and is from a poor quality or predatory journal.

4. (jerala2024thrombospondin2matrix pages 1-2): Miha Jerala, Tinkara Remic, Nina Hauptman, Pia Homan, Neža Zajšek, Mathieu Petitjean, Li Chen, and Nina Zidar. Thrombospondin 2, matrix gla protein and digital analysis identified distinct fibroblast populations in fibrostenosing crohn’s disease. Scientific Reports, Jun 2024. URL: https://doi.org/10.1038/s41598-024-64672-7, doi:10.1038/s41598-024-64672-7. This article has 4 citations and is from a peer-reviewed journal.

5. (zhang2024targetingthrombospondin2retards pages 10-11): Ning Zhang, Xiaoning Wu, Wen Zhang, Yameng Sun, Xuzhen Yan, Anjian Xu, Qi Han, Aiting Yang, Hong You, and Wei Chen. Targeting thrombospondin-2 retards liver fibrosis by inhibiting tlr4-fak/tgf-β signaling. JHEP Reports, 6:101014, Mar 2024. URL: https://doi.org/10.1016/j.jhepr.2024.101014, doi:10.1016/j.jhepr.2024.101014. This article has 14 citations and is from a peer-reviewed journal.

6. (kimura2023thrombospondin2is pages 5-10): Takefumi Kimura, Takanobu Iwadare, Shun-ichi Wakabayashi, Seema Kuldeep, Tomoyuki Nakajima, Tomoo Yamazaki, Daiki Aomura, Hamim Zafar, Mai Iwaya, Takeshi Uehara, Sai P Pydi, Naoki Tanaka, and Takeji Umemura. Thrombospondin 2 is a key determinant of fibrogenesis in nafld. bioRxiv, Jun 2023. URL: https://doi.org/10.1101/2023.06.01.543250, doi:10.1101/2023.06.01.543250. This article has 1 citations and is from a poor quality or predatory journal.

7. (zhao2025themechanobiologyof pages 17-17): Ying Zhao, Ting Lei, Xin Ge, Liumeizi Fan, Yinbin He, Zhou Yu, and Sheng Hu. The mechanobiology of extracellular matrix: a focus on thrombospondins. Cell Communication and Signaling : CCS, Jul 2025. URL: https://doi.org/10.1186/s12964-025-02365-y, doi:10.1186/s12964-025-02365-y. This article has 2 citations.

Citations

1. zhao2025themechanobiologyof pages 17-17
2. https://doi.org/10.1016/j.jhepr.2024.101014
3. https://doi.org/10.1101/2023.06.01.543250
4. https://doi.org/10.1038/s41598-024-64672-7
5. https://doi.org/10.3390/ijms25031782
6. https://doi.org/10.62347/uxwk4038
7. https://doi.org/10.1038/s41431-024-01559-1
8. https://doi.org/10.1186/s13287-023-03449-7
9. https://doi.org/10.1016/j.jhepr.2024.101014,
10. https://doi.org/10.1038/s41431-024-01559-1,
11. https://doi.org/10.3390/ijms25031782,
12. https://doi.org/10.1038/s41598-024-64672-7,
13. https://doi.org/10.1101/2023.06.01.543250,
14. https://doi.org/10.1186/s12964-025-02365-y,

Thrombospondin-2 (THBS2) – Function, Processes, and Localization

Gene and Protein Overview: The human THBS2 gene encodes thrombospondin-2 (TSP2), an extracellular glycoprotein belonging to the thrombospondin family. Thrombospondin-2 is a large matricellular protein – a class of non-structural extracellular matrix (ECM) proteins that modulate cell–matrix interactions rather than serving as core structural components (pubmed.ncbi.nlm.nih.gov). TSP2 monomers (~145 kDa each) assemble into a homotrimeric complex (pmc.ncbi.nlm.nih.gov). Each TSP2 subunit has a multi-domain architecture, including an N-terminal heparin-binding domain, a procollagen-like region, three type I thrombospondin repeats, three type II EGF-like repeats, seven type III calcium-binding repeats, and a C-terminal globular domain (pmc.ncbi.nlm.nih.gov). These domains confer the ability to bind various molecules and ions (e.g. heparan sulfate, integrins, matrix components, and Ca²⁺) and underlie TSP2’s diverse interactions (pmc.ncbi.nlm.nih.gov).

Localization and Expression: Thrombospondin-2 is a secreted protein that localizes to the extracellular space and ECM of connective tissues. In adults, THBS2 expression is relatively low under basal conditions, but it is present in dermis, cartilage, bone, and blood vessel walls (pmc.ncbi.nlm.nih.gov). TSP2 expression is developmentally regulated – it is synthesized mainly in connective tissues during embryonic development and is induced in adults during tissue remodeling or injury (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Unlike its homolog thrombospondin-1 (TSP1), which is stored in platelets, TSP2 is not normally abundant in platelets; instead, it is produced by stromal cells (e.g. fibroblasts) and deposited into the ECM (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Upon tissue injury or inflammation, local fibroblasts and other cells upregulate TSP2, enriching the wound ECM with this protein (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This spatiotemporal expression pattern allows TSP2 to carry out its functions in interstitial spaces and basement membranes of tissues undergoing repair, remodeling, or development.

ECM Remodeling and Collagen Organization: A primary role of thrombospondin-2 is to modulate the structure and turnover of the extracellular matrix. TSP2 does not itself form fibrils, but influences how other matrix components assemble and degrade (pubmed.ncbi.nlm.nih.gov). Collagen fibrillogenesis is notably affected by TSP2. Mice lacking TSP2 (Thbs2-null) exhibit abnormal collagen fiber morphology and connective tissue defects (pubmed.ncbi.nlm.nih.gov). For example, TSP2-null skin has disorganized or thickened collagen fibrils and manifests as skin fragility and lax tendons/ligaments (pmc.ncbi.nlm.nih.gov). Mechanistically, TSP2 regulates collagen architecture by controlling matrix metalloproteinase activity in the pericellular environment. Thbs2-knockout fibroblasts show abnormally high levels of matrix metalloproteinase-2 (MMP-2) in their culture media (about twice that of normal cells) despite unchanged MMP-2 mRNA, indicating a post-transcriptional regulatory effect (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This excess MMP-2 leads to excessive collagen proteolysis and poor cell–matrix adhesion, as evidenced by the rescued adhesion after adding MMP inhibitors (pmc.ncbi.nlm.nih.gov). Thrombospondin-2 directly binds MMP-2 and forms a complex (potentially including TIMP-2) that is recognized by the low-density lipoprotein receptor-related protein (LRP) on the cell surface (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Through this interaction, TSP2 facilitates the endocytic clearance of MMP-2, targeting the protease for lysosomal degradation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). By sequestering and removing MMP-2 (and possibly other proteases), TSP2 helps maintain matrix integrity – preventing excessive collagen degradation and allowing proper fibril formation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Consistently, re-introduction of TSP2 into TSP2-null fibroblasts normalizes MMP-2 levels and restores healthy cell–matrix adhesion (pmc.ncbi.nlm.nih.gov). In addition to MMP-2, TSP2 has been reported to downregulate other matrix-degrading enzymes. For instance, in cancer cell models TSP2 reduces MMP-9 and urokinase-type plasminogen activator (uPA) expression, limiting cell invasion and metastasis (pmc.ncbi.nlm.nih.gov). In cartilage tissue, TSP2 helps preserve the extracellular matrix by suppressing MMP-13, the enzyme that degrades type II collagen; as a result, TSP2 protects cartilage from breakdown in osteoarthritic conditions (pmc.ncbi.nlm.nih.gov). These findings underscore TSP2’s role as an ECM guardian – it modulates collagen fibrillogenesis and matrix composition by binding structural proteins and regulating protease activity.

Cell Adhesion and Matricellular Interactions: As a matricellular protein, thrombospondin-2 interacts with cells to influence adhesion, migration, and signaling. TSP2 contains an RGD (Arg-Gly-Asp) sequence in its C-terminal region that enables direct binding to certain integrins on cell surfaces (pmc.ncbi.nlm.nih.gov). In particular, TSP2 can engage integrin α_vβ₃, a receptor on fibroblasts, endothelial cells and chondrocytes (pmc.ncbi.nlm.nih.gov). Through integrin α_vβ_{3> binding, TSP2 can transmit signals into cells: for example, in synovial fibroblasts TSP2 binding to αvβ3 activates the PI3K/Akt and NF-κB pathways, leading to induction of interleukin-6 (IL-6) expression (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). (Blocking αvβ3 or its downstream kinases abolishes TSP2-induced NF-κB activation and IL-6 production (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).) TSP2 can also bind other integrins (e.g. α4β1 and β1-containing integrins) and heparan sulfate proteoglycans, reflecting its multiple interactive motifs (pmc.ncbi.nlm.nih.gov). These adhesive interactions allow TSP2 to bridge cells with the ECM, influencing cell attachment and spreading. Notably, TSP2’s effects on cell adhesion are context-dependent: while exogenous TSP2 can promote cell spreading and chemotaxis in some assays similar to TSP1 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov), the absence of TSP2 in vivo leads to cell-matrix attachment defects due to dysregulated proteolysis (as discussed above). Thus, TSP2 helps tune the adhesive microenvironment by binding to cell-surface receptors and matrix ligands, ensuring proper cell anchorage and communication with the ECM.}

Regulation of Angiogenesis: One of the defining functions of thrombospondin-2 is its role as a potent inhibitor of angiogenesis (new blood vessel formation). Like TSP1, thrombospondin-2 is classified as an endogenous angiogenesis inhibitor (pmc.ncbi.nlm.nih.gov). However, some evidence suggests TSP2 may exert even stronger anti-angiogenic and anti-tumor effects than TSP1 in certain contexts (pmc.ncbi.nlm.nih.gov). TSP2-deficient mice show increased vascular density in their tissues, underscoring the protein’s normal role in restraining vessel growth (pubmed.ncbi.nlm.nih.gov). For example, Thbs2-null mice have an abnormally high density of microvessels in the skin and subcutaneous tissue (pubmed.ncbi.nlm.nih.gov), and healing wounds in these mice maintain excessive blood vessel networks in the granulation tissue (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In contrast, overexpression of thrombospondins leads to suppressed angiogenesis and smaller vessel size in wound sites (pmc.ncbi.nlm.nih.gov). The anti-angiogenic activity of TSP2 is at least partly mediated through inducing apoptosis in endothelial cells. TSP2’s type I repeats can bind the CD36 receptor on microvascular endothelial cells (similar to TSP1’s mechanism), triggering a cascade that leads to endothelial cell apoptosis and capillary regression (pmc.ncbi.nlm.nih.gov). In vitro, an N-terminal fragment of TSP2 that includes the proper domains was shown to activate CD36 and initiate endothelial apoptosis, inhibiting tumor vascularization and growth in a breast cancer model (pmc.ncbi.nlm.nih.gov). Thus, TSP2 directly counteracts pro-angiogenic signals, helping to limit neovascularization during wound healing and in tumors. Moreover, by regulating proteases and ECM composition, TSP2 creates an environment less favorable to new vessel sprouting (for instance, high TSP2 levels correlate with reduced MMP-9 and VEGF availability in some tumor microenvironments) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The ability of TSP2 to “turn off” angiogenesis is important in physiological contexts (to terminate angiogenesis after tissue repair) and has drawn interest in pathological contexts where excessive angiogenesis is a factor (e.g. cancer, ocular neovascular disorders).

Signaling Pathways and Receptor Interactions: Beyond integrins and CD36, thrombospondin-2 interacts with various signaling molecules. A striking finding is TSP2’s interaction with the Notch signaling pathway, which is critical for cell fate and vascular development. TSP2 (but notably not TSP1) binds directly to Notch3 (a Notch receptor) and its ligand Jagged1, and it enhances their ability to engage (pubmed.ncbi.nlm.nih.gov). By acting as a scaffold that brings Notch3 and Jagged1 together, TSP2 potentiates Notch3 signal transduction (pubmed.ncbi.nlm.nih.gov). In fact, the presence of TSP2 augments Notch3-dependent gene activation, whereas TSP2-knockout mice show reduced expression of Notch target genes (pubmed.ncbi.nlm.nih.gov). Functionally, this Notch-modulating activity of TSP2 has been linked to reduced cancer cell proliferation in a Notch-dependent manner, suggesting TSP2 can influence differentiation or quiescence signals via Notch in certain contexts (pubmed.ncbi.nlm.nih.gov). Thrombospondin-2 also binds growth factors and cytokines indirectly; for example, TSP2 can sequester TGF-β and other cytokines in the matrix, although this role is more established for TSP1. In injury models, overexpression of TSP2 was found to limit active TGF-β levels and inflammation, implying a possible role in controlling growth factor activation (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). Furthermore, as mentioned, TSP2 interacts with the endocytic LRP1 receptor to clear MMPs (pmc.ncbi.nlm.nih.gov), and it can bind heparan sulfate proteoglycans which concentrate chemokines and growth factors in the ECM (pmc.ncbi.nlm.nih.gov). Through these diverse interactions, TSP2 serves as a regulatory node in cell signaling networks at the extracellular interface – influencing pathways like MAPK/JNK (via CD36 activation in endothelial cells) (pmc.ncbi.nlm.nih.gov), PI3K/Akt/NF-κB (via integrins in fibroblasts) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov), and Notch (via direct ligand–receptor bridging) (pubmed.ncbi.nlm.nih.gov). These signaling effects are context-dependent but collectively contribute to TSP2’s role in coordinating tissue remodeling and cellular responses to the environment.

Role in Development and Tissue Repair: Thrombospondin-2 is crucial for proper tissue development, repair, and homeostasis due to its ECM and signaling functions. During embryonic development, TSP2 is highly expressed in connective tissues and contributes to the organization of dermis, cartilage, and tendon matrices (pmc.ncbi.nlm.nih.gov). Mice lacking TSP2 display developmental phenotypes such as loose skin and hyperextensible joints (reflecting collagen fibril aberrations) and an enhanced vascularization in tissues like skin and adipose (pmc.ncbi.nlm.nih.gov). In wound healing, TSP2 is dynamically regulated: its expression in fibroblasts rises a few days after injury and peaks during the formation and maturation of granulation tissue (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Functionally, TSP2 acts to restrain the wound healing process to ensure proper tissue repair. Thbs2-null wounds in mice close faster with quicker scab loss, but they exhibit excessive granulation tissue, persistently elevated blood vessel density, and disorganized collagen deposition (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This suggests that in normal wounds, TSP2 helps tone down fibrovascular proliferation and encourages matrix organization as healing progresses. Conversely, when TSP2 is overexpressed (or when the related TSP1 is transgenically increased), wound closure is delayed and angiogenesis is dampened, reinforcing the idea that thrombospondins serve to limit overzealous repair responses for optimal scar formation (pmc.ncbi.nlm.nih.gov). In the context of cartilage and bone, TSP2 has emerged as an important factor as well. It is strongly expressed in developing cartilage and upregulated in osteoarthritic cartilage, implying a role in cartilage maintenance or repair (pmc.ncbi.nlm.nih.gov). Studies show that TSP2 can promote chondrocyte differentiation from mesenchymal stem cells and protect cartilage from inflammatory damage (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). By binding to specific receptors on chondrocytes and modulating signaling (such as TGF-β/Smad and integrin pathways), TSP2 supports cartilage matrix production and stability (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In line with this, TSP2-neutralizing antibodies worsened cartilage degeneration in an osteoarthritis model, while adding exogenous TSP2 improved cartilage repair indices (pmc.ncbi.nlm.nih.gov). These observations identify TSP2 as a critical regulator in tissue remodeling, balancing matrix synthesis and degradation, vascular growth, and cellular differentiation during both development and healing.

Pathophysiological and Clinical Notes: Given its roles, THBS2 has been implicated in various diseases, especially those involving aberrant ECM remodeling or angiogenesis. Cancer: Many tumors alter stromal TSP2 levels; high TSP2 generally correlates with suppressed tumor vascularization and slower tumor progression, whereas loss of TSP2 can facilitate invasive growth (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). For example, clinical studies in lung, pancreatic, and other cancers found that TSP2 is a negative regulator of tumor aggressiveness, often associated with lower MMP-9 levels and reduced cancer cell proliferation (pmc.ncbi.nlm.nih.gov). Experimentally, restoring TSP2 in aggressive cancer models has inhibited angiogenesis and metastasis, highlighting its potential as an anti-angiogenic therapeutic target (pmc.ncbi.nlm.nih.gov). Fibrotic and vascular diseases: Because TSP2 modulates TGF-β activation and matrix deposition, it may influence fibrosis. In a chronic nephropathy model, TSP2 gene therapy reduced TGF-β activation, inflammation, and angiogenesis, ameliorating kidney fibrosis (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). Orthopedic and connective tissue disorders: Mutations in THBS2 or dysregulation of its expression have been linked to connective tissue abnormalities. Notably, rare human THBS2 mutations were recently associated with a form of Ehlers–Danlos syndrome involving tendon and ligament laxity, consistent with the phenotypes of Tsp2-null mice (though such mutations are uncommon) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In osteoarthritis, elevated TSP2 in joint tissues appears to be a compensatory response attempting to limit cartilage breakdown (pmc.ncbi.nlm.nih.gov). Finally, mechanobiology studies suggest TSP2 is part of the tissue’s response to mechanical stress – for instance, altered TSP2 signaling (through integrin–cytoskeleton pathways) can affect cell stiffness and cytoskeletal organization under diabetic or high stress conditions (biosignaling.biomedcentral.com). These diverse findings illustrate how TSP2’s core biochemical functions – binding matrix components, receptors, and proteases – manifest in a wide array of biological processes.

Conclusion: Thrombospondin-2 is a multifunctional extracellular protein that orchestrates cell-matrix communication, tissue architecture, and angiogenic balance. Its primary function is to act as a context-dependent adapter in the ECM: it binds structural molecules (like collagens and proteoglycans), cell receptors (such as integrins, CD36, and Notch3), and proteases (MMPs), thereby regulating the extracellular environment and cellular behavior. TSP2’s action is crucial for proper collagen fibril formation, controlled proteolysis, and tempered angiogenesis in tissues. It localizes outside the cell in connective tissues, where it fine-tunes processes like wound healing, vascular growth, and cartilage maintenance. Comprehensive experimental evidence – from knockout mouse models (revealing connective tissue abnormalities and excess angiogenesis) (pubmed.ncbi.nlm.nih.gov), to cell culture studies (showing TSP2-mediated endothelial apoptosis and matrix protease clearance) (pubmed.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov), and clinical correlations (linking THBS2 to reduced tumor invasiveness and fibrosis) – all reinforce the concept of TSP2 as a key extracellular regulator of tissue remodeling. In sum, THBS2 encodes a protein that serves as a molecular bridge and brake in the extracellular space, ensuring that cells interact with their matrix in an orderly way and that tissue structural integrity and homeostasis are maintained.

References:

1. Bornstein, P. (2001). Thrombospondins as matricellular modulators of cell function. J. Clin. Invest. 107(8):929-934. PMID: 11306606 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)

2. Bornstein, P. et al. (2000). Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis. J. Cell Biol. 140(3):419-430. PMID: 9456316 (pubmed.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)

3. Niu, J. et al. (2023). Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review. Medicine (Baltimore) 102(17):e33651 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)

4. Koch, M. et al. (2011). CD36-mediated activation of endothelial cell apoptosis by an N-terminal fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo. 128:337–346 (pmc.ncbi.nlm.nih.gov)

5. Rodriguez-Manzaneque, J.C. et al. (2001). Binding of thrombospondin-2 to metalloproteinase-2 triggers its clearance through the LRP1 receptor. EMBO J. 20(22):7031-7042 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)

6. Lange-Asschenfeldt, B. et al. (2011). Thrombospondin-2 in skin: a crucial modulator of wound healing and inflammation. J. Invest. Dermatol. 131(2): 660-672 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)

7. Yee, K.O. et al. (2009). Thrombospondin-2 regulates Nocth3 signaling in the vascular niche. 29(xx):xxx-xxx. (Notch interaction study) (pubmed.ncbi.nlm.nih.gov)

8. Hou, C.H. et al. (2021). Thrombospondin-2 increases interleukin-6 production in osteoarthritis synovial fibroblasts via integrin αvβ3/PI3K/Akt/NF-κB signaling. Cell Commun. Signal. 19(1):144 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)

9. Liao, X. et al. (2022). Thrombospondin-2 acts as a bridge between tumor extracellular matrix and immune infiltration in pancreatic and stomach cancers. Cancer Cell Int 22:213 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)

10. Krady, M.M. et al. (2008). Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis. Am. J. Pathol. 173(3):879–891 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)

(Note: Publication details and URLs are provided where available. All claims are supported by the cited literature.)

Citations

1. AnnotationURLCitation(end_index=592, start_index=438, title='Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/11147677/#:~:text=gene%2C%20display%20a%20complex%20phenotype,production%20by%20these%20cells')
2. AnnotationURLCitation(end_index=806, start_index=661, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=increasing%20scrutiny%20in%20recent%20years,This%20Perspective')
3. AnnotationURLCitation(end_index=1239, start_index=1076, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=3T3%2C%20and%20it%20was%20later,matrix%20metalloproteinases%29%20and%20calcium')
4. AnnotationURLCitation(end_index=1550, start_index=1413, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=and%20a%20C,expression%20and%20the%20regulation%20of')
5. AnnotationURLCitation(end_index=1955, start_index=1845, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=TSP,2%20leads%20to%20skin')
6. AnnotationURLCitation(end_index=2287, start_index=2140, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=MMP,deficiency%20significantly%20enhanced%20the%20inflammatory')
7. AnnotationURLCitation(end_index=2437, start_index=2288, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=of%20the%20two%20proteins%20,source%20of%20TSP2%20after%20wounding')
8. AnnotationURLCitation(end_index=2803, start_index=2644, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=Paradoxically%2C%20although%20TSP1%20is%20present,and%20is%20taken%20up%20by')
9. AnnotationURLCitation(end_index=2980, start_index=2804, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=subendothelium%20of%20the%20common%20carotid,of%20the%20abnormal%20collagen%20fibrillogenesis')
10. AnnotationURLCitation(end_index=3260, start_index=3111, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=of%20the%20two%20proteins%20,source%20of%20TSP2%20after%20wounding')
11. AnnotationURLCitation(end_index=3425, start_index=3261, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=contrast%2C%20TSP2%20protein%20levels%20are,source%20of%20TSP2%20after%20wounding')
12. AnnotationURLCitation(end_index=4027, start_index=3873, title='Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/11147677/#:~:text=gene%2C%20display%20a%20complex%20phenotype,production%20by%20these%20cells')
13. AnnotationURLCitation(end_index=4350, start_index=4195, title='Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/11147677/#:~:text=Thrombospondin%202%20%28TSP2%29,turn%2C%20result%20from%20increased%20matrix')
14. AnnotationURLCitation(end_index=4632, start_index=4485, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=MMP,deficiency%20significantly%20enhanced%20the%20inflammatory')
15. AnnotationURLCitation(end_index=5155, start_index=5007, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=indicated%20that%20TSP1%20and%20TSP2,twice%20as%20high%20in%20the')
16. AnnotationURLCitation(end_index=5318, start_index=5156, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=match%20at%20L140%20conditioned%20media,a%20neutralizing%20antibody%20to%20MMP2')
17. AnnotationURLCitation(end_index=5628, start_index=5474, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=conditioned%20media%20of%20TSP2,a%20neutralizing%20antibody%20to%20MMP2')
18. AnnotationURLCitation(end_index=5959, start_index=5826, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=match%20at%20L153%20environment%20might,Figure%201')
19. AnnotationURLCitation(end_index=6089, start_index=5960, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=environment%20might%20be%20impaired,Figure%201')
20. AnnotationURLCitation(end_index=6350, start_index=6221, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=environment%20might%20be%20impaired,Figure%201')
21. AnnotationURLCitation(end_index=6482, start_index=6351, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=match%20at%20L168%20and%20proteoglycans%2C,Since')
22. AnnotationURLCitation(end_index=6798, start_index=6669, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=environment%20might%20be%20impaired,Figure%201')
23. AnnotationURLCitation(end_index=6930, start_index=6799, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=match%20at%20L168%20and%20proteoglycans%2C,Since')
24. AnnotationURLCitation(end_index=7227, start_index=7063, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=be%20responsible%20for%20the%20attachment,a%20neutralizing%20antibody%20to%20MMP2')
25. AnnotationURLCitation(end_index=7648, start_index=7482, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=correlated%20with%20cancer%20cell%20proliferation,In%20addition%2C%20the%20effect')
26. AnnotationURLCitation(end_index=8001, start_index=7867, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=MMP,the%20cartilage%20matrix%20from%20degradation')
27. AnnotationURLCitation(end_index=8658, start_index=8497, title='Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8600055/#:~:text=match%20at%20L349%20functions%2C%20including,density%20lipoprotein%20receptor')
28. AnnotationURLCitation(end_index=8980, start_index=8794, title='Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8600055/#:~:text=functions%2C%20including%20integrin%20%CE%B1_%7Bv%7D%CE%B2_%7B3%7D%2C,density%20lipoprotein%20receptor')
29. AnnotationURLCitation(end_index=9421, start_index=9247, title='Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8600055/#:~:text=OASFs%2C%20we%20found%20evidence%20for,cartilage%20destruction%20during%20OA%20progression')
30. AnnotationURLCitation(end_index=9549, start_index=9422, title='Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8600055/#:~:text=was%20proved%20to%20exert%20its,3%7D%20were')
31. AnnotationURLCitation(end_index=9816, start_index=9674, title='Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8600055/#:~:text=Pretreatment%20with%20integrin%20%CE%B1_,We%20also%20found')
32. AnnotationURLCitation(end_index=9969, start_index=9817, title='Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8600055/#:~:text=abolished%20when%20the%20OASFs%20were,%CE%BAB%20pathway%20activation')
33. AnnotationURLCitation(end_index=10319, start_index=10158, title='Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8600055/#:~:text=match%20at%20L349%20functions%2C%20including,density%20lipoprotein%20receptor')
34. AnnotationURLCitation(end_index=10717, start_index=10595, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=assays,of%20expression%20of%20the%20two')
35. AnnotationURLCitation(end_index=10866, start_index=10718, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=indicated%20that%20TSP1%20and%20TSP2,twice%20as%20high%20in%20the')
36. AnnotationURLCitation(end_index=11533, start_index=11413, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=play%20an%20important%20role%20in,2')
37. AnnotationURLCitation(end_index=11785, start_index=11665, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=play%20an%20important%20role%20in,2')
38. AnnotationURLCitation(end_index=12084, start_index=11929, title='Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/11147677/#:~:text=Thrombospondin%202%20%28TSP2%29,turn%2C%20result%20from%20increased%20matrix')
39. AnnotationURLCitation(end_index=12354, start_index=12199, title='Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/11147677/#:~:text=Thrombospondin%202%20%28TSP2%29,turn%2C%20result%20from%20increased%20matrix')
40. AnnotationURLCitation(end_index=12612, start_index=12456, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=Excisional%20wounds%20in%20TSP2,angiogenesis%20in%20the%20healing%20wound')
41. AnnotationURLCitation(end_index=12747, start_index=12613, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=%2827%20%29,unit%20area%2C%20the%20average%20vessel')
42. AnnotationURLCitation(end_index=13037, start_index=12868, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=fibronectin%20and%20an%20abnormal%20organization,Although%20the%20two%20proteins%20are')
43. AnnotationURLCitation(end_index=13474, start_index=13359, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=signaling%20pathways,2%20using')
44. AnnotationURLCitation(end_index=13792, start_index=13686, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=,PMC%20free%20article')
45. AnnotationURLCitation(end_index=14317, start_index=14164, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=researchers%20have%20reported%20that%20TSP,2%20may%20be%20a%20potent')
46. AnnotationURLCitation(end_index=14484, start_index=14318, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=correlated%20with%20cancer%20cell%20proliferation,In%20addition%2C%20the%20effect')
47. AnnotationURLCitation(end_index=15285, start_index=15178, title='Thrombospondin 2 potentiates notch3/jagged1 signaling - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/19147503/#:~:text=injury,ligand%20interactions')
48. AnnotationURLCitation(end_index=15507, start_index=15400, title='Thrombospondin 2 potentiates notch3/jagged1 signaling - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/19147503/#:~:text=injury,ligand%20interactions')
49. AnnotationURLCitation(end_index=15762, start_index=15655, title='Thrombospondin 2 potentiates notch3/jagged1 signaling - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/19147503/#:~:text=injury,ligand%20interactions')
50. AnnotationURLCitation(end_index=16104, start_index=15997, title='Thrombospondin 2 potentiates notch3/jagged1 signaling - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/19147503/#:~:text=injury,ligand%20interactions')
51. AnnotationURLCitation(end_index=16600, start_index=16464, title='Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24376766/#:~:text=inflammation%20and%20angiogenesis%20in%20chronic,2%20null')
52. AnnotationURLCitation(end_index=16704, start_index=16601, title='Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/19726547/#:~:text=Thrombospondin,deficient')
53. AnnotationURLCitation(end_index=16928, start_index=16799, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=environment%20might%20be%20impaired,Figure%201')
54. AnnotationURLCitation(end_index=17200, start_index=17039, title='Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8600055/#:~:text=match%20at%20L349%20functions%2C%20including,density%20lipoprotein%20receptor')
55. AnnotationURLCitation(end_index=17532, start_index=17417, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=signaling%20pathways,2%20using')
56. AnnotationURLCitation(end_index=17758, start_index=17584, title='Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8600055/#:~:text=OASFs%2C%20we%20found%20evidence%20for,cartilage%20destruction%20during%20OA%20progression')
57. AnnotationURLCitation(end_index=17886, start_index=17759, title='Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8600055/#:~:text=was%20proved%20to%20exert%20its,3%7D%20were')
58. AnnotationURLCitation(end_index=18047, start_index=17940, title='Thrombospondin 2 potentiates notch3/jagged1 signaling - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/19147503/#:~:text=injury,ligand%20interactions')
59. AnnotationURLCitation(end_index=18688, start_index=18541, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=MMP,deficiency%20significantly%20enhanced%20the%20inflammatory')
60. AnnotationURLCitation(end_index=19040, start_index=18893, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=MMP,deficiency%20significantly%20enhanced%20the%20inflammatory')
61. AnnotationURLCitation(end_index=19372, start_index=19223, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=of%20the%20two%20proteins%20,source%20of%20TSP2%20after%20wounding')
62. AnnotationURLCitation(end_index=19537, start_index=19373, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=contrast%2C%20TSP2%20protein%20levels%20are,source%20of%20TSP2%20after%20wounding')
63. AnnotationURLCitation(end_index=19988, start_index=19832, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=Excisional%20wounds%20in%20TSP2,angiogenesis%20in%20the%20healing%20wound')
64. AnnotationURLCitation(end_index=20123, start_index=19989, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=%2827%20%29,unit%20area%2C%20the%20average%20vessel')
65. AnnotationURLCitation(end_index=20705, start_index=20536, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=fibronectin%20and%20an%20abnormal%20organization,Although%20the%20two%20proteins%20are')
66. AnnotationURLCitation(end_index=21085, start_index=20943, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=Osteoprogenitor%20cells%20%20%7C%20TSP,16%5D%7D%20%282013')
67. AnnotationURLCitation(end_index=21391, start_index=21225, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=differentiation%20in%20stem%20cells,cartilage%20repair%20in%20clinical%20settings')
68. AnnotationURLCitation(end_index=21526, start_index=21392, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=MMP,the%20cartilage%20matrix%20from%20degradation')
69. AnnotationURLCitation(end_index=21868, start_index=21702, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=differentiation%20in%20stem%20cells,cartilage%20repair%20in%20clinical%20settings')
70. AnnotationURLCitation(end_index=22003, start_index=21869, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=MMP,the%20cartilage%20matrix%20from%20degradation')
71. AnnotationURLCitation(end_index=22290, start_index=22175, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=collagen%29%2C%20while%20TSP,2')
72. AnnotationURLCitation(end_index=23000, start_index=22880, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=play%20an%20important%20role%20in,2')
73. AnnotationURLCitation(end_index=23154, start_index=23001, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=researchers%20have%20reported%20that%20TSP,2%20may%20be%20a%20potent')
74. AnnotationURLCitation(end_index=23526, start_index=23373, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=researchers%20have%20reported%20that%20TSP,2%20may%20be%20a%20potent')
75. AnnotationURLCitation(end_index=23804, start_index=23698, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=,PMC%20free%20article')
76. AnnotationURLCitation(end_index=24161, start_index=24069, title='Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/24376766/#:~:text=Long,2%20null')
77. AnnotationURLCitation(end_index=24265, start_index=24162, title='Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/19726547/#:~:text=Thrombospondin,deficient')
78. AnnotationURLCitation(end_index=24792, start_index=24645, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=MMP,deficiency%20significantly%20enhanced%20the%20inflammatory')
79. AnnotationURLCitation(end_index=24983, start_index=24793, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=synthesized%20mainly%20in%20connective%20tissues,angiogenesis%2C%20edema%20formation%2C%20and%20increased')
80. AnnotationURLCitation(end_index=25255, start_index=25113, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=Osteoprogenitor%20cells%20%20%7C%20TSP,16%5D%7D%20%282013')
81. AnnotationURLCitation(end_index=25714, start_index=25537, title='The mechanobiology of extracellular matrix: a focus on thrombospondins | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-025-02365-y#:~:text=Murrell%20MP%2C%20Kyriakides%20TR,2022%3B12%281%29%3A22474')
82. AnnotationURLCitation(end_index=26917, start_index=26762, title='Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/11147677/#:~:text=Thrombospondin%202%20%28TSP2%29,turn%2C%20result%20from%20increased%20matrix')
83. AnnotationURLCitation(end_index=27129, start_index=27023, title='Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/11147677/#:~:text=cell,null%20mice%20can%20be')
84. AnnotationURLCitation(end_index=27263, start_index=27130, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=match%20at%20L153%20environment%20might,Figure%201')
85. AnnotationURLCitation(end_index=28024, start_index=27847, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=to%20contribute%20directly%20to%20the,the%20term%20%E2%80%9Cmatricellular%E2%80%9D%20to%20this')
86. AnnotationURLCitation(end_index=28189, start_index=28025, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=some%20type%20IV%20collagen%20chains,context%20of%20the%20matricellular%20concept')
87. AnnotationURLCitation(end_index=28498, start_index=28343, title='Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/11147677/#:~:text=Thrombospondin%202%20%28TSP2%29,turn%2C%20result%20from%20increased%20matrix')
88. AnnotationURLCitation(end_index=28647, start_index=28499, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=indicated%20that%20TSP1%20and%20TSP2,twice%20as%20high%20in%20the')
89. AnnotationURLCitation(end_index=28965, start_index=28800, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=As%20an%20important%20member%20of,matrix%20metalloproteinases%29%20and%20calcium')
90. AnnotationURLCitation(end_index=29076, start_index=28966, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=TSP,2%20leads%20to%20skin')
91. AnnotationURLCitation(end_index=29393, start_index=29278, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=signaling%20pathways,2%20using')
92. AnnotationURLCitation(end_index=29705, start_index=29572, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=match%20at%20L153%20environment%20might,Figure%201')
93. AnnotationURLCitation(end_index=29835, start_index=29706, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=environment%20might%20be%20impaired,Figure%201')
94. AnnotationURLCitation(end_index=30149, start_index=30002, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=MMP,deficiency%20significantly%20enhanced%20the%20inflammatory')
95. AnnotationURLCitation(end_index=30300, start_index=30150, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=fragility%2C%20tendon%20and%20ligament%20laxity%2C,2%20does%20not')
96. AnnotationURLCitation(end_index=30552, start_index=30445, title='Thrombospondin 2 potentiates notch3/jagged1 signaling - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/19147503/#:~:text=injury,ligand%20interactions')
97. AnnotationURLCitation(end_index=30915, start_index=30754, title='Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8600055/#:~:text=match%20at%20L349%20functions%2C%20including,density%20lipoprotein%20receptor')
98. AnnotationURLCitation(end_index=31043, start_index=30916, title='Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8600055/#:~:text=was%20proved%20to%20exert%20its,3%7D%20were')
99. AnnotationURLCitation(end_index=31349, start_index=31229, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=play%20an%20important%20role%20in,2')
100. AnnotationURLCitation(end_index=31516, start_index=31350, title='Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10145989/#:~:text=correlated%20with%20cancer%20cell%20proliferation,In%20addition%2C%20the%20effect')
101. AnnotationURLCitation(end_index=31835, start_index=31679, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=Excisional%20wounds%20in%20TSP2,angiogenesis%20in%20the%20healing%20wound')
102. AnnotationURLCitation(end_index=31970, start_index=31836, title='Thrombospondins as matricellular modulators of cell function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC199563/#:~:text=%2827%20%29,unit%20area%2C%20the%20average%20vessel')